secwatch / observer
8-K filed September 21, 2021, 7:59 PM ET ticker ABEO CIK 0000318306
leadership confidence high sentiment neutral materiality 0.70

Abeona appoints new CEO, chairman; prepares for two BLA submissions

ABEONA THERAPEUTICS INC.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steven Rouhandeh

Chairman of the Board
ABEO · ABEONA THERAPEUTICS INC.
Effective
2021-10-14
Successor
Michael Amoroso
Filed
September 21, 2021, 7:59 PM ET
Steven Rouhandeh, Chairman of the Board, notified the Company of his retirement and resignation as a member of the Board effective October 14.
Appointed

Vishwas Seshadri

President and Chief Executive Officer and director
ABEO · ABEONA THERAPEUTICS INC.
Effective
2021-10-15
Filed
September 21, 2021, 7:59 PM ET
the Board appointed Vishwas Seshadri, Ph.D., M.B.A., as President and Chief Executive Officer and director effective October 15, 2021.
Departed

Michael Amoroso

President and Chief Executive Officer
ABEO · ABEONA THERAPEUTICS INC.
Effective
2021-10-14
Successor
Vishwas Seshadri
Filed
September 21, 2021, 7:59 PM ET
Michael Amoroso, President and Chief Executive Officer of Abeona Therapeutics Inc. (the “Company”), and a member of the Board of Directors (the “Board”), notified the Company of his resignation as President and Chief Executive Officer effective October 14, 2021.
Appointed

Michael Amoroso

Chairman of the Board
ABEO · ABEONA THERAPEUTICS INC.
Effective
2021-10-15
Filed
September 21, 2021, 7:59 PM ET
the Board voted unanimously to appoint Mr. Amoroso Chairman of the Board effective October 15.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Rouhandeh departed as Chairman of the Board at ABEONA THERAPEUTICS INC..

Action
retired and resigned
Role
Chairman of the Board
Exact text from the filing
Steven Rouhandeh, Chairman of the Board, notified the Company of his retirement and resignation as a member of the Board effective October 14.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Vishwas Seshadri was appointed as President and Chief Executive Officer and director at ABEONA THERAPEUTICS INC..

Action
appointed
Role
President and Chief Executive Officer and director
Exact text from the filing
the Board appointed Vishwas Seshadri, Ph.D., M.B.A., as President and Chief Executive Officer and director effective October 15, 2021.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Amoroso resigned as President and Chief Executive Officer at ABEONA THERAPEUTICS INC..

Action
resigned
Role
President and Chief Executive Officer
Exact text from the filing
Michael Amoroso, President and Chief Executive Officer of Abeona Therapeutics Inc. (the “Company”), and a member of the Board of Directors (the “Board”), notified the Company of his resignation as President and Chief Executive Officer effective October 14, 2021.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Amoroso was appointed as Chairman of the Board at ABEONA THERAPEUTICS INC..

Action
appointed
Role
Chairman of the Board
Exact text from the filing
the Board voted unanimously to appoint Mr. Amoroso Chairman of the Board effective October 15.
View on SEC.gov

ABEONA THERAPEUTICS INC. filing history →

Source: SEC EDGAR
accession 0001493152-21-023269
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.